Biofrontera Inc. Restructuring Charges
Biofrontera Inc. (BFRI) reported Restructuring Charges of $752.00 thousand for the 12-month period ending 2021-12-31, per its 8-K filed 2023-10-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2023-10-03
- Biofrontera Inc. restructuring charges for the quarter ending 2021-12-31 was $98.00K.
- Biofrontera Inc. restructuring charges for the quarter ending 2021-09-30 was $199.00K.
- Biofrontera Inc. restructuring charges for the quarter ending 2021-06-30 was $186.00K.
- Biofrontera Inc. restructuring charges for the quarter ending 2021-03-31 was $281.00K.
- Biofrontera Inc. restructuring charges for fiscal 2020 was $1.13M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|
| 2021-12-31 | $98.00K derived: 8-K 12 month − 10-Q 9 month · filed 2023-10-03 | $297.00K derived: sum of 2 quarters · filed 2023-10-03 | $483.00K derived: sum of 3 quarters · filed 2023-10-03 | $752.00K 8-K · filed 2023-10-03 |
| 2021-09-30 | $199.00K 10-Q · filed 2022-11-14 | $385.00K derived: sum of 2 quarters · filed 2022-11-14 | $654.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $186.00K 10-Q · filed 2022-08-12 | $467.00K 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | $281.00K 10-Q · filed 2022-05-13 | |||
| 2020-12-31 | $1.13M 10-K · filed 2022-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |